1,698 results on '"Tang, W.H. Wilson"'
Search Results
152. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)
153. Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure
154. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure
155. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function
156. Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?
157. Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
158. Reply
159. Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure
160. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)
161. Comparative Efficacy of Cardiac Resynchronization Therapy in Africans Americans Compared With European Americans
162. Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment
163. Comparison of Left Ventricular Torsion and Strain With Biventricular Pacing in Patients With Underlying Right Bundle Branch Block Versus Those With Left Bundle Branch Block
164. Prognostic Comparison of Different Sensitivity Cardiac Troponin Assays in Stable Heart Failure
165. Hyponatremia in Acute Decompensated Heart Failure: Depletion Versus Dilution
166. The Pathophysiological Role of Interstitial Sodium in Heart Failure
167. Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure
168. Renal Failure Requiring Dialysis Complicating Slow Continuous Ultrafiltration in Acute Heart Failure: Importance of Systolic Perfusion Pressure
169. Prognostic Value of Estimating Functional Capacity With the Use of the Duke Activity Status Index in Stable Patients With Chronic Heart Failure
170. Long-Term Outcomes in Patients With Ambulatory New York Heart Association Class III and IV Heart Failure Undergoing Cardiac Resynchronization Therapy
171. Dysregulated amino acid metabolism in heart failure: role of gut microbiome
172. Natriuretic Peptides
173. Retinal Microvasculature
174. Keeping the Failing Heart in Check
175. Prognostic Value of Elevated Serum Ceruloplasmin Levels in Patients With Heart Failure
176. A Combined-Biomarker Approach to Clinical Phenotyping Renal Dysfunction in Heart Failure
177. γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
178. Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure: Refining the Gut Hypothesis
179. Prognostic Value of Glomerular Filtration Changes Versus Natriuretic Response in Decompensated Heart Failure With Reduced Ejection
180. NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?
181. Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study
182. Is epicardial adipose tissue a key pathophysiologic target in heart failure with preserved ejection?
183. Current Approach to the Diagnosis of Sarcopenia in Heart Failure: A Narrative Review on the Role of Clinical and Imaging Assessments
184. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion
185. Stable isotope dilution mass spectrometry quantification of hydrogen sulfide and thiols in biological matrices
186. Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function
187. Relation of Statin Use to Gut Microbial Trimethylamine N-Oxide and Cardiovascular Risk
188. Genetic and Nongenetic Factors Influencing Pharmacokinetics of B-Type Natriuretic Peptide
189. Insufficient Natriuretic Response to Continuous Intravenous Furosemide Is Associated With Poor Long-Term Outcomes in Acute Decompensated Heart Failure
190. Usefulness of Elevated Urine Neopterin Levels in Assessing Cardiac Dysfunction and Exercise Ventilation Inefficiency in Patients With Chronic Systolic Heart Failure
191. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: State of the art review and focus on emerging nuclear techniques
192. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential
193. Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling: A Cardiopulmonary Exercise Testing Imaging Evaluation
194. Abstract 21098: Variables From the CMS Heart Failure Readmission Model Poorly Predict 30-Day Rehospitalization Risk in Heart Failure Patients From a Large Academic Hospital System
195. Abstract 12243: A Contemporary Analysis of Predictors of Mortality in Patients With Heart Failure and Preserved Ejection Fraction From the National Inpatient Sample 2014 Database
196. Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure
197. Gut microbiome and its role in cardiovascular diseases
198. Effects of Thiazolidinediones on Serum Lipoproteins
199. Uptitration of Renin-Angiotensin System Blocker and Beta-Blocker Therapy in Patients Hospitalized for Heart Failure With Reduced Versus Preserved Left Ventricular Ejection Fractions
200. Management of Cardio-Renal Syndrome and Diuretic Resistance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.